Zhejiang Sunflower Health addresses abnormal stock fluctuations

Zhejiang Sunflower Great Health's stock experienced abnormal fluctuations, with its closing price deviation cumulatively exceeding 30% over two consecutive trading days, October 15 and October 16, 2025. The company confirmed no previously disclosed information needs correction or supplementation and no undisclosed major information has been reported by public media that could significantly impact its stock price. Furthermore, the company’s operational situation and internal and external operating environment have not changed recently.

The company is currently planning a major asset restructuring involving the issuance of shares, cash payments to acquire assets, and a capital raising for supporting funds. The related proposal was approved by the board of directors on September 19, 2025, and details were disclosed on September 22, 2025, on cninfo.com.cn. The audit and valuation work for this transaction is ongoing, and a formal plan will be submitted for board approval once completed.

The company's controlling shareholders and actual controllers did not engage in any buying or selling of company shares during the abnormal fluctuation period. Zhejiang Sunflower Great Health also noted it will disclose its Third Quarter Report for 2025 on October 28, 2025, and emphasized that there is no leakage of undisclosed periodic performance information.